Compare KSCP & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KSCP | BTMD |
|---|---|---|
| Founded | 2013 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.1M | 64.4M |
| IPO Year | 2022 | 2021 |
| Metric | KSCP | BTMD |
|---|---|---|
| Price | $3.44 | $2.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $17.00 | $2.83 |
| AVG Volume (30 Days) | ★ 867.9K | 334.7K |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 63.54 | ★ 722.22 |
| EPS | N/A | ★ 0.74 |
| Revenue | $11,335,000.00 | ★ $192,219,000.00 |
| Revenue This Year | $218.66 | $2.03 |
| Revenue Next Year | $54.32 | $6.58 |
| P/E Ratio | ★ N/A | $3.00 |
| Revenue Growth | ★ 4.91 | N/A |
| 52 Week Low | $2.92 | $1.27 |
| 52 Week High | $10.13 | $4.75 |
| Indicator | KSCP | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 43.12 | 71.21 |
| Support Level | $3.09 | $2.02 |
| Resistance Level | $4.50 | $2.79 |
| Average True Range (ATR) | 0.34 | 0.16 |
| MACD | -0.05 | 0.10 |
| Stochastic Oscillator | 17.24 | 91.84 |
Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.